vs
Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and DONALDSON Co INC (DCI). Click either name above to swap in a different company.
Ardent Health, Inc. is the larger business by last-quarter revenue ($1.6B vs $935.4M, roughly 1.7× DONALDSON Co INC). DONALDSON Co INC runs the higher net margin — 12.2% vs 2.8%, a 9.4% gap on every dollar of revenue.
Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.
Donaldson Company, Inc. is a filtration company engaged in the production and marketing of filtration products used in a variety of industry sectors, including commercial/industrial, aerospace, chemical, alternative energy (windmills), food & beverage, and pharmaceuticals. Also the company's research division, located in Minneapolis, Minn., participated in defense-related projects for various military applications.
ARDT vs DCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $935.4M |
| Net Profit | $45.0M | $113.9M |
| Gross Margin | — | 35.2% |
| Operating Margin | 5.8% | 16.0% |
| Net Margin | 2.8% | 12.2% |
| Revenue YoY | — | 3.9% |
| Net Profit YoY | — | 15.1% |
| EPS (diluted) | $0.32 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $935.4M | ||
| Q3 25 | $1.6B | $980.7M | ||
| Q2 25 | $1.6B | $940.1M | ||
| Q1 25 | $1.5B | $870.0M | ||
| Q4 24 | — | $900.1M | ||
| Q3 24 | $1.4B | $935.4M | ||
| Q2 24 | $1.5B | $927.9M | ||
| Q1 24 | — | $876.7M |
| Q4 25 | $45.0M | $113.9M | ||
| Q3 25 | $-23.5M | $114.3M | ||
| Q2 25 | $73.0M | $57.8M | ||
| Q1 25 | $41.4M | $95.9M | ||
| Q4 24 | — | $99.0M | ||
| Q3 24 | $26.3M | $109.7M | ||
| Q2 24 | $42.8M | $113.5M | ||
| Q1 24 | — | $98.7M |
| Q4 25 | — | 35.2% | ||
| Q3 25 | — | 34.5% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 35.5% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | — | 35.2% |
| Q4 25 | 5.8% | 16.0% | ||
| Q3 25 | -0.1% | 15.5% | ||
| Q2 25 | 7.4% | 9.3% | ||
| Q1 25 | 5.0% | 14.4% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | 3.9% | 15.6% | ||
| Q2 24 | 5.6% | 15.5% | ||
| Q1 24 | — | 14.8% |
| Q4 25 | 2.8% | 12.2% | ||
| Q3 25 | -1.5% | 11.7% | ||
| Q2 25 | 4.4% | 6.1% | ||
| Q1 25 | 2.8% | 11.0% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | 1.8% | 11.7% | ||
| Q2 24 | 2.9% | 12.2% | ||
| Q1 24 | — | 11.3% |
| Q4 25 | $0.32 | $0.97 | ||
| Q3 25 | $-0.17 | $0.97 | ||
| Q2 25 | $0.52 | $0.48 | ||
| Q1 25 | $0.29 | $0.79 | ||
| Q4 24 | — | $0.81 | ||
| Q3 24 | $0.19 | $0.90 | ||
| Q2 24 | $0.34 | $0.92 | ||
| Q1 24 | — | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $709.6M | $210.7M |
| Total DebtLower is stronger | $1.1B | $671.5M |
| Stockholders' EquityBook value | $1.3B | $1.5B |
| Total Assets | $5.3B | $3.0B |
| Debt / EquityLower = less leverage | 0.84× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $709.6M | $210.7M | ||
| Q3 25 | $609.4M | $180.4M | ||
| Q2 25 | $540.6M | $178.5M | ||
| Q1 25 | $495.0M | $189.1M | ||
| Q4 24 | — | $221.2M | ||
| Q3 24 | $563.1M | $232.7M | ||
| Q2 24 | $334.5M | $223.7M | ||
| Q1 24 | — | $193.8M |
| Q4 25 | $1.1B | $671.5M | ||
| Q3 25 | $1.1B | $630.4M | ||
| Q2 25 | $1.1B | $638.8M | ||
| Q1 25 | $1.1B | $514.7M | ||
| Q4 24 | — | $538.6M | ||
| Q3 24 | $1.1B | $483.4M | ||
| Q2 24 | $1.1B | $481.8M | ||
| Q1 24 | — | $352.0M |
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $739.9M | $1.5B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $5.3B | $3.0B | ||
| Q3 25 | $5.2B | $3.0B | ||
| Q2 25 | $5.0B | $3.0B | ||
| Q1 25 | $4.9B | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $4.8B | $2.9B | ||
| Q2 24 | $4.6B | $2.9B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | 0.84× | 0.44× | ||
| Q3 25 | 0.88× | 0.43× | ||
| Q2 25 | 0.87× | 0.44× | ||
| Q1 25 | 0.93× | 0.33× | ||
| Q4 24 | — | 0.35× | ||
| Q3 24 | 1.08× | 0.32× | ||
| Q2 24 | 1.46× | 0.32× | ||
| Q1 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $223.4M | $125.4M |
| Free Cash FlowOCF − Capex | — | $111.2M |
| FCF MarginFCF / Revenue | — | 11.9% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 4.97× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $403.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $223.4M | $125.4M | ||
| Q3 25 | $154.4M | $167.8M | ||
| Q2 25 | $117.5M | $87.7M | ||
| Q1 25 | $-24.8M | $90.4M | ||
| Q4 24 | — | $72.9M | ||
| Q3 24 | $89.7M | $126.0M | ||
| Q2 24 | — | $141.5M | ||
| Q1 24 | — | $87.0M |
| Q4 25 | — | $111.2M | ||
| Q3 25 | — | $147.5M | ||
| Q2 25 | — | $73.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $47.9M | ||
| Q3 24 | — | $106.2M | ||
| Q2 24 | — | $120.2M | ||
| Q1 24 | — | $65.7M |
| Q4 25 | — | 11.9% | ||
| Q3 25 | — | 15.0% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 7.5% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.8% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | 4.97× | 1.10× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | 1.61× | 1.52× | ||
| Q1 25 | -0.60× | 0.94× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 3.41× | 1.15× | ||
| Q2 24 | — | 1.25× | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARDT
Segment breakdown not available.
DCI
| Aftermarket Products | $447.1M | 48% |
| Industrial Filtration Solutions Products | $222.6M | 24% |
| Off Road Products | $86.5M | 9% |
| Life Sciences Segment | $80.0M | 9% |
| Other | $39.1M | 4% |
| Aerospace And Defense Products | $37.1M | 4% |
| On Road Products | $23.0M | 2% |
